Company intelligence
Cavidi
Enabling ultra-sensitive immunoassays
Biotechnology Research
Uppsala, SE
20 employees
Founded 1984
3 public signals
About Cavidi
Cavidi is a Swedish biotech firm that is transforming the field of biomarker detection with our groundbreaking solution, Exazym® — the world’s first add-on reagent system that delivers ultra-sensitive detection of low-abundance biomarkers using standard immunoassay workflows. Cavidi's products are used globally by biomedical scientists and researchers working on basic, transitional and pre-clinical biomarker research.
Verified activity
Signals from Cavidi
3 published signals
Presence & Recognition
Cavidi Innovation Week saw the strongest scientific output in the history of the tradition started in 2025 and gaining momentum since.
Reported by Cavidi
Operations & Supply
Cavidi announced that Millésimo Mycology s.r.o. is live, combining precision indoor cultivation with renewable forest energy and circular resource use to produce premium, traceable mushrooms for the European market.
Reported by John R.
Research & Knowledge
Cavidi published an in-depth explainer explaining how BOLD technology makes immunoassays 10–100x more sensitive.
Reported by Cavidi